...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of the Medical Association of Thailand =: Chotmaihet thangphaet >Who's distressed? A comparison of diabetes-related distress by type of diabetes and medication
【24h】

Who's distressed? A comparison of diabetes-related distress by type of diabetes and medication

机译：谁苦恼了？ 糖尿病和药物类型的糖尿病相关窘迫的比较

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

? 2018 ? 2018 Objective: We hypothesized that diabetes-related distress would vary by type of diabetes and medication regimen [Type 1 diabetes (T1DM), Type 2 diabetes with insulin use (T2DM-i), Type 2 diabetes without insulin use (T2DM)]. Thus, the aim of this study was to identify groups with elevated diabetes-related distress. Methods: We administered the 17-item Diabetes-related Distress Scale (DDS-17) to 585 patients. We collected demographics, medications, and lab results from patient records. Results: Patients were categorized by type of diabetes and medication: T1DM (n = 149); T2DM-i (n = 333); and T2DM (n = 103). ANOVA revealed significant differences in sample characteristics. ANCOVA were conducted on all four DDS-17 domains [Emotional Burden (EB); Physician-related Distress (PD); Regimen-related Distress (RD); and Interpersonal Distress (ID)]; covariates included in the models were sex, age, duration of diabetes, BMI, and HbA1c. EB was significantly lower in T1DM than T2DM-i, p 0.05. In addition, RD was significantly lower in T1DM than either T2DM-i, p 0.05 and T2DM, p 0.05. Conclusions: EB and RD are higher for those with type 2 diabetes. Thus, interventions to reduce EB and RD need to be considered for patients with type 2 diabetes. Implications: DDS-17 is useful in identifying diabetes-related distress in patients with diabetes. Efforts need to be made to reduce EB and RD. Objective: We hypothesized that diabetes-related distress would vary by type of diabetes and medication regimen [Type 1 diabetes (T1DM), Type 2 diabetes with insulin use (T2DM-i), Type 2 diabetes without insulin use (T2DM)]. Thus, the aim of this study was to identify groups with elevated diabetes-related distress. Methods: We administered the 17-item Diabetes-related Distress Scale (DDS-17) to 585 patients. We collected demographics, medications, and lab results from patient records. Results: Patients were categorized by type of diabetes and medication: T1DM (n = 149); T2DM-i (n = 333); and T2DM (n = 103). ANOVA revealed significant differences in sample characteristics. ANCOVA were conducted on all four DDS-17 domains [Emotional Burden (EB); Physician-related Distress (PD); Regimen-related Distress (RD); and Interpersonal Distress (ID)]; covariates included in the models were sex, age, duration of diabetes, BMI, and HbA1c. EB was significantly lower in T1DM than T2DM-i, p < 0.05. In addition, RD was significantly lower in T1DM than either T2DM-i, p < 0.05 and T2DM, p < 0.05. Conclusions: EB and RD are higher for those with type 2 diabetes. Thus, interventions to reduce EB and RD need to be considered for patients with type 2 diabetes. Implications: DDS-17 is useful in identifying diabetes-related distress in patients with diabetes. Efforts need to be made to reduce EB and RD.
机译：还2018年？ 2018目的：我们假设糖尿病相关的痛苦会因糖尿病和药物方案的类型而变化[1型糖尿病（T1DM），2型糖尿病，胰岛素使用（T2DM-I），2型糖尿病没有胰岛素使用（T2DM）]。因此，本研究的目的是鉴定糖尿病相关窘迫升高的群体。方法：我们向585名患者施用17项糖尿病相关的痛苦量表（DDS-17）。我们收集了患者记录的人口统计学，药物和实验室结果。结果：患者按糖尿病和药物类型分类：T1DM（n = 149）; T2DM-I（n = 333）;和t2dm（n = 103）。 ANOVA揭示了样本特征的显着差异。 Ancova在所有四个DDS-17领域进行了[情绪负担（EB）;与医生有关的痛苦（PD）;相关救济遇险（RD）;和人际关系遇险（ID）];模型中包含的协变量是性，年龄，糖尿病，BMI和HBA1c的持续时间。 EB在T1DM中显着低于T2DM-I，P＆LT; 0.05。此外，RD在T1DM中显着低于T2DM-I，P＆LTD。 0.05和t2dm，p＆ 0.05。结论：2型糖尿病的人和RD更高。因此，需要考虑减少EB和RD的干预患者2型糖尿病患者。含义：DDS-17可用于鉴定糖尿病患者的糖尿病相关的痛苦。需要努力减少EB和RD。目的：我们假设糖尿病相关的痛苦会因糖尿病和药物方案的类型而变化[型糖尿病（T1DM），2型糖尿病，胰岛素使用（T2DM-I），2型糖尿病，没有胰岛素使用（T2DM）]。因此，本研究的目的是鉴定糖尿病相关窘迫升高的群体。方法：我们向585名患者施用17项糖尿病相关的痛苦量表（DDS-17）。我们收集了患者记录的人口统计学，药物和实验室结果。结果：患者按糖尿病和药物类型分类：T1DM（n = 149）; t2dm-i（n = 333）;和t2dm（n = 103）。 ANOVA揭示了样本特征的显着差异。 Ancova在所有四个DDS-17领域进行了[情绪负担（EB）;与医生有关的痛苦（PD）;相关救济遇险（RD）;和人际关系遇险（ID）];模型中包含的协变量是性，年龄，糖尿病，BMI和HBA1c的持续时间。 EB在T1DM显着低于T2DM-I，P <0.05。此外，RD在T1DM中显着低于T2DM-I，P <0.05和T2DM，P <0.05。结论：2型糖尿病的人和RD更高。因此，需要考虑减少EB和RD的干预患者2型糖尿病患者。含义：DDS-17可用于鉴定糖尿病患者的糖尿病相关的痛苦。需要努力减少EB和RD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号